Free Trial

Analysts Set Cardlytics, Inc. (NASDAQ:CDLX) Price Target at $5.20

Cardlytics logo with Business Services background

Shares of Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) have been given a consensus rating of "Hold" by the seven analysts that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $5.20.

Several equities research analysts have recently commented on CDLX shares. Lake Street Capital decreased their target price on shares of Cardlytics from $3.00 to $2.50 and set a "hold" rating for the company in a research report on Thursday, May 8th. Evercore ISI decreased their target price on shares of Cardlytics from $4.00 to $3.00 and set an "in-line" rating for the company in a research report on Thursday, March 13th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Cardlytics in a research report on Thursday, March 13th.

Get Our Latest Research Report on Cardlytics

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Tallon Kerry Patrick purchased a new position in Cardlytics during the fourth quarter worth about $37,000. Jump Financial LLC purchased a new position in Cardlytics during the first quarter worth about $41,000. ProShare Advisors LLC purchased a new position in Cardlytics during the fourth quarter worth about $43,000. Virtu Financial LLC purchased a new position in Cardlytics during the fourth quarter worth about $62,000. Finally, Intech Investment Management LLC boosted its holdings in Cardlytics by 31.3% during the fourth quarter. Intech Investment Management LLC now owns 19,310 shares of the company's stock worth $72,000 after purchasing an additional 4,607 shares during the last quarter. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

Cardlytics Stock Up 6.5%

CDLX traded up $0.11 during midday trading on Wednesday, hitting $1.79. The company had a trading volume of 239,006 shares, compared to its average volume of 974,104. Cardlytics has a 52 week low of $1.22 and a 52 week high of $9.78. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The company has a market capitalization of $93.98 million, a price-to-earnings ratio of -0.29 and a beta of 1.25. The stock's 50 day moving average price is $1.71 and its 200 day moving average price is $2.67.

About Cardlytics

(Get Free Report

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Should You Invest $1,000 in Cardlytics Right Now?

Before you consider Cardlytics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardlytics wasn't on the list.

While Cardlytics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines